Đánh giá kết quả của “bột thuốc đắp HV” trên người bệnh thoái hóa khớp gối nguyên phát

Abstract

Objective: to evaluate the results of “Bot thuoc dap HV” on patients with primary knee osteoarthritis.

Subjects and methods: a controlled clinical trial was performed in 60 patients with primary knee osteoarthritis. Patients were randomly divided into 2 groups, each group of 30 patients: study group (Glucosamine + “Bot thuoc dap HV”); control group (Glucosamine + infrared light). The study period was from Apr 2021 to Oct 2021.

Results: After 20 days of treatment, the study group had a pain reduction performance on the VAS scale of 4.20 ± 1.10 (points) and the control group was 3.53 ± 1.43 (points) (p<0.05). The performance of score increase in knee flexion range of motion in the study group and control group was 31.8 ± 7.62 (degrees)

and 25.8 ± 12.1 (degrees), respectively (p<0.05). The performance of score reduction of heel-buttock index in the study group was 13.30 ± 4.86 (cm) and the control group was 10.40 ± 5.93 (cm) (p<0.05). The performance of WOMAC score increase in the study group and control group was 41.20 ± 13.6 (points) and

• ± 0 (points), respectively (p<0.05).

Conclusions: “Bot thuoc dap HV” is effective in reducing pain and improving the range of motion of the knee flexion, heel-buttock index, and WOMAC index of the patients.